A convenient, easy to use, and rapid alternative to blood-based HIV testing may become the new standard for field testing according to a new MUHC study. The study shows that the oral fluid-based OraQuick HIV1/2 test is 100 per cent accurate and patients’ preferred choice.
Senior and lead author Dr. Nitika Pai, a postdoctoral fellow at the McGill University Health Centre (MUHC), and her colleagues tested 450 individuals for HIV infection at the Mahatma Gandhi Institute of Medical Sciences in Sevagram India. Thirty two percent were found to be HIV positive. Researchers compared the diagnostic accuracy of the OraQuick test from two samples - one obtained from oral fluid (saliva) and the other from a blood-based finger stick - with traditional blood tests.
They demonstrated that the oral fluid test had 100 per cent accuracy versus the finger-stick blood test, which showed one false positive (99.7 per cent specificity). There was little reported discomfort during sample collection for the oral test, but 66 per cent of the individuals reported discomfort with the finger testing.
Although the oral OraQuick test has been approved by the US Food and Drug Administration, some previous studies had indicated that it was not sufficiently precise. As a result, the Centre for Disease Control (CDC) called for more definitive studies leading to this study in rural India.
"Based on our findings, the oral test is the preferred choice for HIV field testing by rural Indians," says Dr. Pai, a physician epidemiologist supported by the Canadian HIV Trials Network. "The other advantages are that results are available within 40 minutes compared to the standard blood test, which takes up to two weeks. This test can also be performed by health workers with minimal training, eliminating the need for specialist laboratory technicians."
"Rapid point of care HIV testing is a very important component of HIV control initiatives and programs. In particular, non-invasive, simple, accurate oral fluid-based, rapid tests have the potential to make a big impact on HIV screening. They open the door to the possibility of home-based HIV testing," she says.
Source: McGill University
Related stories:
HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study
In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for preventing the virus.
New treatment for hepatitis C
Researchers at the University of Oklahoma Health Sciences Center have found a new use for an old drug. Their findings appear online in the
American Journal of Gastroenterology.
Spit tests may soon replace many blood tests
One day soon patients may spit in a cup, instead of bracing for a needle prick, when being tested for cancer, heart disease or diabetes. A major step in that direction is the cataloguing of the “complete” salivary proteome, a set of proteins in human ductal saliva, identified by a consortium of three research teams, according to an article published today in the Journal of Proteome Research. Replacing blood draws with saliva tests promises to make disease diagnosis, as well as the tracking of treatment efficacy, less invasive and costly.
Existing antiretroviral drugs may thwart vaginal HIV transmission, researchers report
Prescription drugs now used to treat human immunodeficiency virus infection in adults may prevent the vaginal transmission of HIV, researchers at UT Southwestern Medical Center have found.
Scientists find rabies-based vaccine could be effective against HIV
Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists at Jefferson Medical College in Philadelphia have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease. The early evidence shows that the vaccine – which doesn’t protect against infection – prevents development of disease.
New lab-on-a-chip can detect heart and gum disease instantly
Someday in the not-too-distant future patients may visit a doctor’s office, provide a sample of saliva or blood, and know in minutes if they are prone to heart disease, gum disease, or cancer. There would be no sending samples to off-site labs for analysis and waiting days to obtain the vital information.
A five-pound, hand-held medical diagnostic device being developed at the National Nuclear Security Administration’s Sandia National Laboratories promises to be this ticket to better health for millions of Americans.
Study reveals gap in HIV testing knowledge among college students
Most college students understand how they can prevent the transmission of HIV but are less knowledgeable about HIV testing, according to a new University of Georgia study.
Women may stop anticoagulants after blood clots
Women may safely discontinue oral anticoagulants (blood thinners) after 6 months of treatment following a first unprovoked venous blood clot (thromboembolism) if they have no or one risk factor, concludes a study of 646 participants in a multicentre prospective cohort study.